Aquaporin-2 as a biomarker of distal renal tubular function using lithium as an experimental model

Renal Failure

Volumn 21, Issue 3-4, 1999, Pages 331-336

  Sisson, David ^a   Batlle, Daniel ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Aquaporin 2; Lithium; Nephrogenic diabetes insipidus

Indexed keywords

AQUAPORIN; BIOLOGICAL MARKER; LITHIUM;

CONFERENCE PAPER; CONTROLLED STUDY; DEHYDRATION; DIABETES INSIPIDUS; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY DISTAL TUBULE; KIDNEY TUBULE FUNCTION; MAJOR CLINICAL STUDY; NEPHROTOXICITY; POLYURIA; PRIORITY JOURNAL; PROTEIN URINE LEVEL;

EID: 0032983983     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.3109/08860229909085095     Document Type: Conference Paper

References (35)

1. Boron R, Gaviria M, Batlle DC: Prevalence, pathologenesis, and treatment of renal dysfunction associated with chronic lithium therapy. Am J Kidney Dis 10(5):329-345, 1987.
2. Godinich MJ, Batlle DC: Renal tubular effects of lithium. Kidney Int 37 (suppl 28):552-557, 1990.
3. Walker RG, Bennet WM, Davies BM: Structural and functional aspects of long term lithium therapy. Kidney Int 21:513-529, 1982.
4. Albrecht J, Kampf D, Muller-Oerlinghausen B: Renal function and biopsy in patients on lithium therapy. Pharmaco-psychiatrie 13:228-234, 1980.
5. Bendz H, Andersch S, Aurell M: Kidney function in an unselected lithium population A cross-sectional study. Acta Psychiatry Scand 68:325-334, 1983.
6. Lokkegaard H, Anderson HF, Henriksen E, Bartels PD, Brahm M, Baastrup PC, Joprgensen HE, Larsen M, Munck O, Rasmussen K: Renal function in 153 manic-depressive patients treated with lithium for more than five years. Acta Psychiatry Scand 71:347-355, 1985.
7. Baylis PH, Heath DA: Water disturbances in patients treated with oral lithium carbonate. Arm Intern Med 88:607-609, 1978.
8. Uldall PR, Awad AG, McCormick WO, Carter LB, Gonsick T, Grass CL, Kugelmass MI: Renal function in patients receiving long-term lithium therapy. CMAJ 142:1471-1474, 1981.
9. Wahlin A, Bucht G, Von Knomng L, Smigan L: Kidney function in patients with affective disorders with and without lithium therapy. Pharmacopsychiatry 15:253-259, 1980.
10. Wallin L, Aling C, Aurell M: Impairment of renal function in patients on long-term lithium treatment. Clin Nephrol 18:23-28, 1982.
11. Donker AJM, Pins B, Meijer S, Sluiter W, Van Berkestijn JW, Dols LC: A renal function study in 30 patients on long-term lithium therapy. Clin Nephrol 254-262, 1979.
12. Vestergaard F, Amdisen A, Hansen AB, Schou M: Lithium treatment and kidney function. Acta Psychiatry Scand 60:504-520, 1979.
13. Johnson GF, Hunt Gm, Duggin GG, Horvath JJ, Tiller DJ: Renal function abnd lithium treatment initial and follow-up tests in manic-depressive patients. J Affective Disord 249-263, 1984.
14. Coppen A, Bishop ME, Bailey JE, Cattel WR, Price RG: Renal function in lithium and non-lithium-treated patients wit affective disorders. Acta Psychiatry Scand 62:343-355, 1980.
15. GrofF, MacCrimmon DJ, Smith EKM, Daigle L, Saxena B, Varma R, GrofE, Keitner G, Kenny J: Long-term lithium treatment and the Kidney. Can J Psychiatry 25:535-444, 1980.
16. Jorgensen F, Larsen S, Spanager E, Clausen B, Tango M, Brinch B, Brun C: Kidney function and quantitative histological changes in patients on long-term lithium therapy. Acta Psychiatry Scand 70:455-462, 1984.
17. Batlle DC, vonRiotte AB, Baviari M, Grupp M: Amelioration of poryuria by amiloride in patients receiving long-tern lithium therapy. N Engl J Med 312:409-414, 1985.
18. Lehmann K, Ritz E: Angiotensin-converting enzyme inhibitors may cause renal dysfunction in patients on long-term lithium treatment. Am J Kidney Dis 25:82-87, 1995.
19. Ragheb M: The clinical significance of lithium-non-steroidal antiinflammatory drug interactions. J Clin Psychopharmacol 10:350-354, 1990.
20. Singer I, Rottnberg D, Puschett YB: Lithikum-induced nephrogenic diabetes insipidus in vivo and in vitro studies. J Clin Invest 51:1081-1091, 1972.
21. Singer I, Franko EA: Lithium-induced ADH resistance in toad bladders. Kidney Int 3:151-159, 1973.
22. Forrest J Jr, Cohen AD, Toretti J, Himmelhoch JM, Epstein FH: On the mechanism of lithium-induced diabetes insipidus in man and the rat. J Clin Invest 53:115-123, 1974.
23. Martinez-Maldinado M Stravroulaki-Tsapar A, Tsaparas N: Renal effects of lithium administration in rats alterations in water and electrolyte metabolism and the response to vasopressin and cyclic adenosine monophosphate during prolonged administration. J Lab Clin Med 86:445-446, 1975.
24. Femandez-Repollet B, Le Furgey A, Hardy MA, Tisher CC: Structural and functional response of toad urinary bladder of LiCl. Kidney Int 24:719-730, 1983.
25. Harris CA, Jenner FA: Some aspects of the inhibition of the action of antidiuretic hormone by lithium ions in the rat kidney and bladder of the toad. Bufo maririus. Brit J Pharmacol 44:223-232, 1972.
26. Cogan B, Abramow M: Inhibiton by lithium of the hydroosmotic action of vasopressin in the isolated perfused conical collecting tubule of the rabbit. J Clin Invest 77: 1507-1514, 1986.
27. Chnstiensen S, Kusano E, Yusufi ANK: Pathogenesis of nephrogenic diabetes insipidus due to chronic administration of lithium in rats. J Clin Invest 75:1869-1879, 1985.
28. Dousa TP, Barnes LD: Lithium-induced diuretic effect of antidiuretic hormone in rats. Am J Physiol 231:1754-1759, 1976.
29. Jackson BA et al.: Lithium-induced polyuna effect of lithium on adenylate cyclase and adenosine 3'S' monophosphate phosphodiesterase in medullary ascending limb of Henle's loop and in medullary collecting tubules. Endocrinol 107(6):1693-1698, 1980.
30. Yamaki M, Kusasno E, Homma S: Cellular mechanisms of lithium induced nephrogenic diabetes insipidus. Am Soc Nephrol 404A, 1989.
31. Batlle DC, Baviria M, Grupp M: Distal nephron function in patients receiving chronic lithium therapy. Kidney Int 21:477-485, 1982.
32. Nielsen S, Ottosen F, Christensen E, Christensen S, Marples D: Lithium-induced Down regulation of Aquaporin-2 Water Channel Expression in Rat Kidney. Medulla J Clinl nv 95:1838-1845, 1995.
33. Deen P, van Aubel R, van Lieburg A, van Os C: Urinary Content of Aquporin 1 and 2 in Nephrogenic Diabetes Insipidus. J Am Soc Nenh 6:836-841, 1996.
34. Brenner BM, Berliner RW: Relationship between extra-cellular volume and fluid reabsorption by the rat nephron. Am J Physiol 217:6-12, 1969.
35. Jung R: Urinary enzymes and low molecular weight proteins as markers of tubular dysfunction: Micro-proteins and enzymes as tubular markers. Kidney Int 46:529-533, 1994.